Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xtant Medical Holdings Inc (XTNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 14,472
  • Shares Outstanding, K 18,090
  • Annual Sales, $ 90,000 K
  • Annual Income, $ -19,490 K
  • 36-Month Beta 0.74
  • Price/Sales 0.16
  • Price/Cash Flow 0.00
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.37
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/07/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.61 +27.87%
on 07/07/17
0.94 -17.02%
on 07/10/17
+0.09 (+13.04%)
since 06/23/17
3-Month
0.36 +116.67%
on 05/12/17
0.94 -17.02%
on 07/10/17
+0.26 (+50.00%)
since 04/25/17
52-Week
0.29 +168.97%
on 01/31/17
1.98 -60.61%
on 08/01/16
-0.99 (-55.93%)
since 07/25/16

Most Recent Stories

More News
Xtant Medical to Announce Second Quarter 2017 Results on August 9th, 2017

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the second...

XTNT : 0.78 (+1.30%)
Medical Equipment Stock Performance Review -- Xtant Medical, Second Sight Medical Products, Lantheus, and Masimo

If you want a Stock Review on XTNT, EYES, LNTH or MASI then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Four Medical Appliances and Equipment...

EYES : 1.23 (-0.81%)
LNTH : 19.27 (+0.63%)
MASI : 98.48 (+0.12%)
XTNT : 0.78 (+1.30%)
Xtant Medical Announces Rescheduling of Annual Meeting

Xtant(TM) Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its board of directors has rescheduled the Company's...

XTNT : 0.78 (+1.30%)
Xtant Medical Enters into Licensing Agreement for Sites Medical's OsteoSync Ti Technology

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced it has entered into...

XTNT : 0.78 (+1.30%)
Xtant Medical Announces OrbiMed Financing and Engagement of Aurora Management Partners

Xtant(TM) Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced it has entered into an amendment to its senior credit...

XTNT : 0.78 (+1.30%)
Xtant Medical Announces Release of First Quarter 2017 Results on May 9, 2017

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, announced that it will release its financial results for the First Quarter...

XTNT : 0.78 (+1.30%)
Xtant Medical Recognized as Montana Ambassador Business of the Year

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced it has been named as...

XTNT : 0.78 (+1.30%)
Xtant(TM) Medical Receives Going Concern Opinion

Xtant(TM) Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that as previously disclosed in its Annual Report on...

XTNT : 0.78 (+1.30%)
Research Reports Initiation on Medical Equipment Stocks -- Varex Imaging, Masimo, Varian Medical, and Xtant Medical

Companies in the Medical Appliances and Equipment space are engaged in the manufacture of medical instruments such as dental and surgical appliances. They also tend to offer below-average dividend yields...

VAR : 103.89 (-0.55%)
VREX : 31.71 (+0.44%)
MASI : 98.48 (+0.12%)
XTNT : 0.78 (+1.30%)
Biotech and Pharma Stocks Rise on Optimism in the Markets Fueling Acquisitions and new Product Launches

PALM BEACH, Florida, March 7, 2017 /PRNewswire/ --

TGTX : 11.62 (-3.57%)
IPXL : 19.33 (+3.09%)
XTNT : 0.78 (+1.30%)
BLPH : 1.45 (-2.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery...

See More

Support & Resistance

2nd Resistance Point 0.84
1st Resistance Point 0.80
Last Price 0.78
1st Support Level 0.75
2nd Support Level 0.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.